Cargando…
The Impact of Metformin on Tumor-Infiltrated Immune Cells: Preclinical and Clinical Studies
The tumor microenvironment (TME) plays a pivotal role in the fate of cancer cells, and tumor-infiltrating immune cells have emerged as key players in shaping this complex milieu. Cancer is one of the leading causes of death in the world. The most common standard treatments for cancer are surgery, ra...
Autores principales: | Abdelmoneim, Mohamed, Aboalela, Mona Alhussein, Naoe, Yoshinori, Matsumura, Shigeru, Eissa, Ibrahim Ragab, Bustos-Villalobos, Itzel, Sibal, Patricia Angela, Takido, Yuhei, Kodera, Yasuhiro, Kasuya, Hideki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487782/ https://www.ncbi.nlm.nih.gov/pubmed/37686159 http://dx.doi.org/10.3390/ijms241713353 |
Ejemplares similares
-
Metformin enhances the antitumor activity of oncolytic herpes simplex virus HF10 (canerpaturev) in a pancreatic cell cancer subcutaneous model
por: Abdelmoneim, Mohamed, et al.
Publicado: (2022) -
C-REV Retains High Infectivity Regardless of the Expression Levels of cGAS and STING in Cultured Pancreatic Cancer Cells
por: Morimoto, Daishi, et al.
Publicado: (2021) -
S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model
por: Miyajima, Noriyuki, et al.
Publicado: (2021) -
Genomic Signature of the Natural Oncolytic Herpes Simplex Virus HF10 and Its Therapeutic Role in Preclinical and Clinical Trials
por: Eissa, Ibrahim Ragab, et al.
Publicado: (2017) -
The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers
por: Eissa, Ibrahim Ragab, et al.
Publicado: (2018)